AN1 0.00% 0.8¢ anagenics limited

Ann: Agreement Signed for Sale of Lyramid Limited, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,290 Posts.
    lightbulb Created with Sketch. 244
    So the net operational cash flow after 9 months was -$2,106K.
    Take away the 1 off Ikon payment of $1,407K, which leaves -$784K.
    Add back the R&D rebate of $646K makes the net cash outflow -$1,400K.
    Then take away the presumed annual cost reduction of $1,000K or $750K for nine months and net cash outflow is -$650K for nine months, or -$867K annualised.

    On that basis with $8.5M in the bank they wouldn't need a CR for 10 years.

    Last years sales were $7.1M in the 3rd Quarter as opposed to the current $5.1M

    If this years sales were the same we would be $1, 450K cashflow POSITIVE.

    Run your slide rule over that!


 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.